Resultados: 1332

    Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma

    Next Evidence-based recommendations on nivolumab (Opdivo) with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma in adults. Commercial arrangement There is a commercial access agreement for nivolumab...

    Transcutaneous electrical stimulation of the trigeminal nerve for ADHD

    Evidence-based recommendations on transcutaneous electrical stimulation of the trigeminal nerve for ADHD. This involves a single-use electrode patch stuck to the forehead, which sends small electrical pulses through the skin during sleep. Is this guidance up to date? Next review: 2026...

    Percutaneous image-guided cryoablation of peripheral neuroma for chronic pain

    Evidence-based recommendations on percutaneous image-guided cryoablation of peripheral neuroma for chronic pain. This involves using a needle-like probe to freeze and destroy small parts of nerves in neuromas to stop the pain signals. Is this guidance up to date? Next review: 2026...

    Mobocertinib for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy

    Evidence-based recommendations on mobocertinib (EXKIVITY) for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy in adults. Commercial arrangement There is a simple discount patient access scheme for mobocertinib. NHS organisations ca...

    Upadacitinib for treating moderately to severely active ulcerative colitis

    Evidence-based recommendations on upadacitinib (Rinvoq) for treating moderately to severely active ulcerative colitis in adults. Commercial arrangement There is a simple discount patient access scheme for upadacitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. ...

    The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

    The American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) developed this Clinical Practice Guideline on the Management of Stimulant Use Disorder (hereafter referred to as the Guideline) to provide evidence-based strategies and standards of care for the trea...

    British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023

    Now that the majority of people living with HIV take combination antiretroviral therapy (ART), the spectrum of causes of pyrexia of unknown origin (PUO) has changed compared with the pre-ART era. In these guidelines, we focus on causes and evaluation of PUO among people living with HIV with CD4 counts <3...

    ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

    Ann. rheum. dis; 82 (1), 2023
    To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR recommendations for the management of axial spondyloarthritis (axSpA). Following the EULAR Standardised Operating Procedures, two systematic literature reviews were conducted on non-pharmacological and pharmacological treatm...

    Guía de Práctica Clínica Nacional para el tratamiento con potenciadores y moduladores del Regulador de la Conductancia Transmembrana de la Fibrosis Quística

    La fibrosis quística (FQ) es una enfermedad crónica y progresiva, de origen genético, de herencia autosómica recesiva, causada por mutaciones en el gen que codifica para la proteína reguladora de la conductancia transmembrana de la fibrosis quística (CFTR su sigla del inglés Cystic Fibrosis Transm...

    Guía de práctica clínica nacional sobre abordaje Integral de la obesidad en personas adultas

    La presente Guía de Práctica Clínica (GPC) fue impulsada por la DNAIENT, en el marco de las políticas que el Ministerio de Salud de la Nación lleva adelante para reducir la morbimortalidad asociada a las enfermedades no transmisibles y sus factores de riesgo, y reemplaza a la versión precedente del...